Advances in Clinical Dentistry Research – Information Page
Series Editor
Forthcoming
Editorial Board Members
Forthcoming
Notes for Contributors
Advances in Clinical Dentistry Research is a peer-reviewed book series owned and operated by Nova Science Publishers and funded entirely by purchase orders and author-optional publication services. Each installment of the book series is available in print and electronic formats and sent to all the major index houses for evaluation.
There is no charge to submit or publish your work in the book series. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of your work. These services include Open Access, color printing, chapter offprints, discounted print copies, and licenses for use of the published chapters.
Authors may deposit and display the accepted versions of their work in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published works only after a period of one year has elapsed from the day of publication. Authors may obtain reproduction and republication rights for their chapters by transacting with Copyright Clearance Center or with Nova directly.
Manuscript Submissions
Before submitting your work, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.
Submission of a manuscript must be accompanied by a signed Copyright Transfer and Disclosure Form, which can be printed or downloaded here: https://novapublishers.com/wp-content/uploads/2021/09/CTDF-Copyright-Transfer-and-Disclosure-Form.pdf. Submissions that do not include a signed Copyright Transfer and Disclosure Form will be treated as incomplete.
Chapters should be submitted by email to the Editor listed below.
Forthcoming
It is understood that works submitted to the series have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new work is an expansion of the original, in which case full transparency of the re-used portions must be provided. Please note that your work cannot be retracted or withdrawn after it has been published.
It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.
Manuscript Preparation
Works reporting results of original research should be divided into Introduction, Materials and Methods, Results, Discussion, Acknowledgements (if any), and References. The abstract of the work usually contains these subdivision headings and summarizes each of them. All abstracts and works must be written in English with references in standard Roman script.
Illustrations
All diagrams, photographs, illustrations, and charts should be referred to in the text as Figures, and they should be numbered consecutively with Arabic numerals. These figures must be supplied as separate electronic files named in the format in which they were created, and they must be one of the following types: tiff, bitmap, jpeg, gif, ppt, psd, png, or eps. The resolution of these figures must be at least 300 dpi. All illustrations should be accompanied by suitable legends and kept to the minimum essential for proper presentation of the results of findings. Legends are required for all illustrations and should be provided as editable text separate from the figures. For photomicrographs, legends must specify original magnification and stain (if used).
Figures must also be placed inside or at the end of the manuscript. If scanned images are used, please retain the original hard copy of the figure for possible transmission to Nova Science Publishers. If previously published figures are used, written permission from the copyright holders must be obtained and submitted along with the text indicating the copyright holder’s citation instructions. Such permissions must grant unrestricted use.
Tables
Tables should be logically organized, and they should supplement the information provided in the text. Each table should be typed on a separate page with the number, title, and footnotes. Tables should be kept to the minimum essential for proper presentation of the results or findings. Permissions from author and publisher must be obtained for the direct use of previously published material including text, photographs, drawings, etc. The permission should be included with the manuscript.
References
All references and only those cited in the text should appear in the list of references. They should be numbered consecutively as they appear in the text of the paper.
Examples:
Journals:
Subbaiyan, H. Ajitha, P. Regenerative Techniques in Management of Large Periapical Lesions: A Case Series. Int J Clin Dent. 2021;(14)4:445-454.
Books:
Lanzafame, Raymond J. Designing, Executing, Communicating and Interpreting: Essential Considerations for Furthering the Science and Application of Photobiomodulation and Photomedicine. In: Romanos, Georgios. Laser Light Therapy in Dentistry: Efficacy, Uses and Limitations. New York: Nova Science Publishers. 2021;3-15
Papers in the course of publication should only be entered in the references if they have been accepted for publication and then given in the standard manner in the text and in the list of references with the publication title, accompanied by “In press.”
Peer-Review
The series uses double-blind peer-review. The identities of both reviewers and authors are concealed from each other throughout the review. To facilitate this, authors must ensure that their manuscripts are prepared in such a way that they do not reveal their identities to reviewers, either directly or indirectly. Please therefore ensure that the following items are present in your submission and provided as separate files.
– Anonymized Manuscript
– Title Page
– Abstract Page
Anonymized Manuscript
Please remove any identifying information, such as authors’ names or affiliations, from your manuscript before submission. As well as removing names and affiliations under the title within the manuscript, other steps need to be taken to ensure the manuscript is correctly prepared for double blind peer review. The key points to consider are:
Use the third person to refer to work the authors have previously published. For example, write “Black and Hart (2015) have previously demonstrated” rather than “we/the authors have previously demonstrated (Black & Hart, 2015).”
Make sure that figures and tables do not contain any reference to author affiliations.
Choose file names with care, and ensure that the file’s “properties” are also anonymised. If you are using Office 2007 or later, consider using the Document Inspector Tool prior to submission.
Title Page
The Title Page will remain separate from the manuscript throughout the peer-review process and will not be sent to the reviewers. The Title Page should include:
– The manuscript title
– All authors’ complete names and complete affiliations
– A complete address for the corresponding author, including an e-mail address
Abstract Page
The abstract page should follow the title page and contain only the title of the manuscript and the abstract. The abstract should have the following sections: Purpose, Methods, and Results. As a separate sentence after the abstract, a short statement should highlight the clinical significance of the manuscript.
Editorial Team
The editorial team works diligently to maintain the quality of the content, and their responsibilities are many. Together they:
• identify trending, emerging, and important topics of research within their specific fields of study;
• recruit authors of quality research for publication;
• coordinate and oversee the peer-review process;
• liaise with authors, reviewers, and the publisher;
• write editorials;
• perform technical and developmental editing of manuscripts;
• act as the series’ ambassadors to the global scientific community;
Publication Ethics and Research Conduct
Nova and its editors are committed to maintaining trust in our published content, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. Guidelines are for transparency are provided below to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.
Plagiarism
Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material.
The Editors will use CrossCheck and/or other software to screen submitted manuscripts for plagiarism and will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher, the editorial office, the author’s institute, and other governing bodies as necessary. Plagiarized works already accepted for publication will be cancelled, and plagiarized works that have already been published will be retracted and denounced in a public erratum.
Transparency
In order to establish transparency in your research, authors must be sure to provide statements on the following items.
1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statements of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.
The appropriate statements are provided below. They should be included in the manuscript’s text in a section titled Ethical Compliance. This section should immediately precede the References section.
1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.
Statement
Source of Funding: This study was funded by ____________________.
2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.
Possible or perceived conflicts of interest among peer reviewers are handled by the Editors. A request for the reviewer to disclose all possible or perceived conflicts of interest will be included with all invitations for peer-review. When possible or perceived conflicts of interest are present, peer reviewers are expected to recuse themselves. When editors, editorial board members, and other members of the editorial team have possible or perceived conflicts of interests with content that is submitted to them, they should recuse themselves and reassign their tasks to other capable members. If possible or perceived conflict of interest cannot be avoided by reassignment, it should be suggested to the submitting author that he/she submit to a different publication.
The Committee on Publication Ethics provides guidelines for investigating the suspected non-disclosure of conflicts of interest.
https://publicationethics.org/guidance/Flowcharts
Statement
a) Disclosure of Interest: The authors declare that they have no conflict of interest.
or
b) Disclosure of Interest:
3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.
Statement
Informed consent was obtained from each individual participant involved in this study.
4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors must include a statement to assure us that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
Statement
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
5) Statement of Animal Welfare
All studies that involve animals must contain a statement to assure us that the study and its procedures were approved by their affiliate institutional research ethics committees.
Statement
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.
Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.
The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you conduct your research and publish with Nova and any other scientific publisher.
https://publicationethics.org/resources/code-conduct
If you notice any ethical misconduct in Nova’s publications, please contact us.
Publisher’s Office
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
E-mail: nova.main@novapublishers.com
Advertising Opportunities
Please contact our office using the information above.
Archiving
The series content is preserved electronically to ensure that access can continue in perpetuity if the series ceases publication. Nova will comply with NISO standards in the event of transfer between publishers.
